JG
ANIK icon

Joel Greenblatt’s Anika Therapeutics ANIK Stock Holding History

Joel Greenblatt’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,426
Closed -$393K – 1022
2020
Q2 		$393K Sell
10,426
-19,988
-66% -$659K 0.01% 804
2020
Q1 		$879K Buy
30,414
+11,036
+57% +$446K 0.02% 577
2019
Q4 		$1M Buy
19,378
+9,356
+93% +$543K 0.02% 619
2019
Q3 		$550K Buy
10,022
+958
+11% +$49.2K 0.01% 740
2019
Q2 		$368K Buy
+9,064
New +$331K 0.01% 885
2018
Q3 		– Sell
-6,624
Closed -$212K – 923
2018
Q2 		$212K Sell
6,624
-24,711
-79% -$1.02M ﹤0.01% 835
2018
Q1 		$1.56M Sell
31,335
-4,252
-12% -$240K 0.02% 544
2017
Q4 		$1.92M Sell
35,587
-7,340
-17% -$406K 0.03% 501
2017
Q3 		$2.49M Buy
42,927
+9,101
+27% +$476K 0.04% 480
2017
Q2 		$1.67M Buy
33,826
+11,162
+49% +$514K 0.02% 555
2017
Q1 		$985K Sell
22,664
-19,615
-46% -$936K 0.01% 669
2016
Q4 		$2.07M Sell
42,279
-37,007
-47% -$1.71M 0.03% 504
2016
Q3 		$3.79M Sell
79,286
-119,017
-60% -$5.88M 0.05% 405
2016
Q2 		$10.6M Buy
198,303
+35,195
+22% +$1.66M 0.13% 261
2016
Q1 		$7.29M Buy
163,108
+58,662
+56% +$2.38M 0.08% 347
2015
Q4 		$3.99M Buy
104,446
+15,259
+17% +$584K 0.04% 449
2015
Q3 		$2.84M Sell
89,187
-169,296
-65% -$5.9M 0.03% 501
2015
Q2 		$8.54M Sell
258,483
-20,095
-7% -$717K 0.07% 373
2015
Q1 		$11.5M Sell
278,578
-68,609
-20% -$2.77M 0.09% 320
2014
Q4 		$14.1M Sell
347,187
-28,566
-8% -$1.12M 0.11% 272
2014
Q3 		$13.8M Buy
375,753
+140,354
+60% +$6.06M 0.14% 235
2014
Q2 		$10.9M Buy
+235,399
New +$10.5M 0.14% 237
2013
Q4 		– Sell
-68,532
Closed -$1.64M – 959
2013
Q3 		$1.64M Buy
+68,532
New +$1.54M 0.05% 487

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Joel Greenblatt's ANIK Position: Q3 2020 in Review

Joel Greenblatt sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 10,426 shares — an estimated $393K sold.

Joel Greenblatt first reported a position in ANIK in Q3 2013 and held it in 23 quarters. The position peaked at $14.1M in Q4 2014. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.

  • Joel Greenblatt reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Joel Greenblatt sold 10,426 Anika Therapeutics shares in Q3 2020, an estimated $393K.
  • Joel Greenblatt first reported a position in Anika Therapeutics in Q3 2013 and held it in 23 quarters.
  • Joel Greenblatt's Anika Therapeutics position peaked at $14.1M in Q4 2014.
  • 156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.

Based on Gotham Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.